Furthermore, during CML, we have observed a functional defect in the innate CD8(+) T-cell population, a finding suggesting not only that CML innate CD8(+) T cells are in the process of being exhausted but also that they could be a target of immune blocking checkpoints. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.